Abstract 1159: Targeting novel mucin synthesis pathway for pancreatic cancer treatment

Author(s):  
Altaf Mohammed ◽  
Naveena B. Janakiram ◽  
Venkateshwar Madka ◽  
Gaurav Kumar ◽  
Scott Edgar ◽  
...  
2012 ◽  
Vol 13 (6) ◽  
pp. 802-810 ◽  
Author(s):  
T. Troiani ◽  
E. Martinelli ◽  
A. Capasso ◽  
F. Morgillo ◽  
Michele Orditura ◽  
...  

2021 ◽  
pp. 133362
Author(s):  
Xiao Fu ◽  
Xiaoxuan Zhang ◽  
Danqing Huang ◽  
Liang Mao ◽  
Yudong Qiu ◽  
...  

Author(s):  
Diana S. Hsu ◽  
Nikathan S. Kumar ◽  
Sidney T. Le ◽  
Alex L. Chang ◽  
George Kazantsev ◽  
...  

Cell Reports ◽  
2021 ◽  
Vol 37 (9) ◽  
pp. 110060
Author(s):  
Jennifer E. Klomp ◽  
Ye S. Lee ◽  
Craig M. Goodwin ◽  
Björn Papke ◽  
Jeff A. Klomp ◽  
...  

Author(s):  
Amrallah A. Mohammad

Presentation of pancreatic cancer is localized, locally advanced or metastatic. With the later represented the main bulk (more than 80%). Despite the significant innovation in molecular analysis and therapeutic approach in many types of cancer in the last two decades, still the outcome of advanced pancreatic cancer is disappointing and the mortality rate approximately unchanged. In this mandated review we intended to highlight the standard of care and emerging agents for advanced pancreatic cancer treatment.


2018 ◽  
Vol 87 (6) ◽  
pp. 1474-1480 ◽  
Author(s):  
Herve Tiriac ◽  
Juan Carlos Bucobo ◽  
Demetrios Tzimas ◽  
Suman Grewel ◽  
Joseph F. Lacomb ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document